Insulin sensitivity is not associated with palmitoleate availability in obese humans

Research output: Contribution to journalArticle

37 Scopus citations


We evaluated whether insulin resistance in obese people is associated with decreased plasma palmitoleate availability. Palmitoleate content (percentage and absolute concentrations) in FFA and VLDL was measured in obese subjects who were either insulin resistant (IR) or insulin sensitive (IS), based on assessment of multiorgan (skeletal muscle, liver, and adipose tissue) insulin sensitivity by using the hyperinsulinemic-euglycemic clamp procedure in conjunction with infusion of stable isotopically labeled tracers. Plasma palmitoleate concentration and the relative contribution of palmitoleate to total plasma FFA concentration in the IS group (0.018 ± 0.002 mmol/l and 4.4% ± 0.2%, respectively) were not significantly different than values in the IR group (0.023 ± 0.003 mmol/l and 4.4% ± 0.4%, respectively). Plasma VLDL-triglyceride palmitoleate concentration and the proportion of VLDL fatty acids as palmitoleate in the IS group (0.09 ± 0.02 mmol/l and 5.7 ± 0.3%, respectively) were also not significantly different than those in the IR group (0.16 ± 0.04 mmol/l and 5.0% ± 0.4%, respectively). These data demonstrate that decreased palmitoleate in plasma and in VLDL is not associated with insulin resistance in skeletal muscle, liver, or adipose tissue in obese people.

Original languageEnglish
Pages (from-to)808-812
Number of pages5
JournalJournal of lipid research
Issue number4
StatePublished - Apr 1 2011


  • Free fatty acid
  • Gas chromatography
  • Hyperinsulinemic-euglycemic clamp
  • Stable isotope tracers

Fingerprint Dive into the research topics of 'Insulin sensitivity is not associated with palmitoleate availability in obese humans'. Together they form a unique fingerprint.

  • Cite this